. 2016 May 1;30(9):1002–1019. doi: 10.1101/gad.279737.116
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
Table 2.
Clinical trials testing drugs targeting CAFs
